Cargando…

Reliability of Retinal Pathology Quantification in Age-Related Macular Degeneration: Implications for Clinical Trials and Machine Learning Applications

PURPOSE: To investigate the interreader agreement for grading of retinal alterations in age-related macular degeneration (AMD) using a reading center setting. METHODS: In this cross-sectional case series, spectral-domain optical coherence tomography (OCT; Topcon 3D OCT, Tokyo, Japan) scans of 112 ey...

Descripción completa

Detalles Bibliográficos
Autores principales:	Müller, Philipp L., Liefers, Bart, Treis, Tim, Rodrigues, Filipa Gomes, Olvera-Barrios, Abraham, Paul, Bobby, Dhingra, Narendra, Lotery, Andrew, Bailey, Clare, Taylor, Paul, Sánchez, Clarisa I., Tufail, Adnan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Association for Research in Vision and Ophthalmology 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938003/ https://www.ncbi.nlm.nih.gov/pubmed/34003938 http://dx.doi.org/10.1167/tvst.10.3.4

Ejemplares similares

Estimating excess visual loss from neovascular age-related macular degeneration in the UK during the COVID-19 pandemic: a retrospective clinical audit and simulation model
por: Thomas, Darren S, et al.
Publicado: (2022)

Quantification and Predictors of OCT-Based Macular Curvature and Dome-Shaped Configuration: Results From the UK Biobank
por: Müller, Philipp L., et al.
Publicado: (2022)

Contextualizing single‐arm trials with real‐world data: An emulated target trial comparing therapies for neovascular age‐related macular degeneration
por: Thomas, Darren S., et al.
Publicado: (2021)

Beyond the Complement Cascade: Insights into Systemic Immunosenescence and Inflammaging in Age-Related Macular Degeneration and Current Barriers to Treatment
por: Khan, Adnan H., et al.
Publicado: (2023)

Initial clinical experience of ranibizumab therapy for neovascular age-related macular degeneration
por: Rotsos, Tryfon, et al.
Publicado: (2010)

Management of Neovascular Age-Related Macular Degeneration in Clinical Practice: Initiation, Maintenance, and Discontinuation of Therapy
por: Keane, Pearse A., et al.
Publicado: (2011)

Epigenetics in age-related macular degeneration: new discoveries and future perspectives
por: Gemenetzi, M., et al.
Publicado: (2020)

Gene, Cell and Antibody-Based Therapies for the Treatment of Age-Related Macular Degeneration
por: Akyol, Engin, et al.
Publicado: (2020)

Ten-year outcome of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration
por: Upasani, Deepa, et al.
Publicado: (2021)

Complement factor I and age-related macular degeneration
por: Alexander, Philip, et al.
Publicado: (2014)

Socioeconomic risk factors and age-related macular degeneration in the UK Biobank study
por: Yip, Jennifer Lai Yee, et al.
Publicado: (2021)

Strategies for improving early detection and diagnosis of neovascular age-related macular degeneration
por: Keane, Pearse A, et al.
Publicado: (2015)

Age-Related Macular Degeneration: A Disease of Systemic or Local Complement Dysregulation?
por: Warwick, Alasdair, et al.
Publicado: (2014)

Macular thickness varies with age-related macular degeneration genetic risk variants in the UK Biobank cohort
por: Kaye, Rebecca A., et al.
Publicado: (2021)

Modelling Cost Effectiveness in Neovascular Age-Related Macular Degeneration: The Impact of Using Contrast Sensitivity vs. Visual Acuity
por: Butt, Thomas, et al.
Publicado: (2014)

Epigenetic Age Acceleration Is Not Associated with Age-Related Macular Degeneration
por: Saptarshi, Neil, et al.
Publicado: (2021)

Chlamydia infection status, genotype, and age-related macular degeneration
por: Khandhadia, Sam, et al.
Publicado: (2012)

Patterns of treatment discontinuation in patients receiving anti-vascular endothelial growth factor for neovascular age-related macular degeneration
por: Dhingra, Narendra, et al.
Publicado: (2022)

Quantification of Visual Field Loss in Age-Related Macular Degeneration
por: Acton, Jennifer H., et al.
Publicado: (2012)

Y chromosome mosaicism is associated with age-related macular degeneration
por: Grassmann, Felix, et al.
Publicado: (2018)

Rare complement factor I variants associated with reduced macular thickness and age-related macular degeneration in the UK Biobank
por: Tzoumas, Nikolaos, et al.
Publicado: (2022)

Challenges in studying geographic atrophy (GA) age-related macular degeneration: the potential of a new mouse model with GA-like features
por: Ratnayaka, J. Arjuna, et al.
Publicado: (2019)

Distribution and Quantification of Choroidal Macrophages in Human Eyes With Age-Related Macular Degeneration
por: McLeod, D. Scott, et al.
Publicado: (2016)

A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin(® )(Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design
por: Patel, Praveen J, et al.
Publicado: (2008)

The complexities underlying age-related macular degeneration: could amyloid beta play an important role?
por: Lynn, Savannah A., et al.
Publicado: (2017)

Repeatability of retinal thickness and volume metrics in neovascular age-related macular degeneration using the topcon 3doct-1000
por: Tah, Vikas, et al.
Publicado: (2014)

Three-Year Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting
por: Eleftheriadou, Maria, et al.
Publicado: (2018)

Association of Smoking, Alcohol Consumption, Blood Pressure, Body Mass Index, and Glycemic Risk Factors With Age-Related Macular Degeneration: A Mendelian Randomization Study
por: Kuan, Valerie, et al.
Publicado: (2021)

A retrospective study of the real-life utilization and effectiveness of ranibizumab therapy for neovascular age-related macular degeneration in the UK
por: Hykin, Philip, et al.
Publicado: (2016)

Cross Sectional and Longitudinal Associations between Cardiovascular Risk Factors and Age Related Macular Degeneration in the EPIC-Norfolk Eye Study
por: Yip, Jennifer L. Y., et al.
Publicado: (2015)

Monitoring for neovascular age-related macular degeneration (AMD) reactivation at home: the MONARCH study
por: Ward, Elizabeth, et al.
Publicado: (2020)

CLINICAL EVIDENCE OF THE MULTIFACTORIAL NATURE OF DIABETIC MACULAR EDEMA
por: Chakravarthy, Usha, et al.
Publicado: (2018)

Diagnostic Accuracy of Monitoring Tests of Fellow Eyes in Patients with Unilateral Neovascular Age-Related Macular Degeneration: Early Detection of Neovascular Age-Related Macular Degeneration Study
por: Sivaprasad, Sobha, et al.
Publicado: (2021)

Real world evidence on 5661 patients treated for macular oedema secondary to branch retinal vein occlusion with intravitreal anti-vascular endothelial growth factor, intravitreal dexamethasone or macular laser
por: Gale, Richard, et al.
Publicado: (2021)

Macrophages and Macular Degeneration
por: Jager, Martine J.
Publicado: (2014)

Brolucizumab for macular degeneration
Publicado: (2020)

Optic Flow Processing in Patients With Macular Degeneration
por: Guénot, Jade, et al.
Publicado: (2022)

Age-related macular degeneration: choroidal ischaemia?
por: Coleman, D Jackson, et al.
Publicado: (2013)

Automatic Quantification Software for Geographic Atrophy Associated with Age-Related Macular Degeneration: A Validation Study
por: Ruiz-Moreno, José M., et al.
Publicado: (2020)

Brolucizumab: evidence to date in the treatment of neovascular age-related macular degeneration
por: Yannuzzi, Nicolas A, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cfthr9ravdhrsg4scmmms7fig7